Methylation as a modulator of expression of human immunodeficiency virus
- PMID: 3469417
- PMCID: PMC254089
- DOI: 10.1128/JVI.61.4.1253-1257.1987
Methylation as a modulator of expression of human immunodeficiency virus
Abstract
When Vero or murine cells were stably transfected with the human immunodeficiency virus (HIV) long terminal repeat (LTR) that directs the chloramphenicol acetyltransferase (CAT) gene (pU3R-III-CAT), expression was suppressed. Treatment with the nucleoside analog 5-azacytidine (5-azaC) restored CAT expression. S1 nuclease analysis and a nuclear run-on assay demonstrated that activation of the latent HIV LTR by 5-azacytidine occurred at the transcriptional level. Southern blot analysis demonstrated that this activation was due to the demethylation of cytosine residues in the LTR enhancer. Thus, the HIV LTR appears to be susceptible to transcriptional inactivation by methylation, a process that is proposed to play a modulatory role in viral latency.
Similar articles
-
Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.Proc Natl Acad Sci U S A. 1987 Nov;84(21):7408-12. doi: 10.1073/pnas.84.21.7408. Proc Natl Acad Sci U S A. 1987. PMID: 2823260 Free PMC article.
-
Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro.Haematol Blood Transfus. 1987;31:423-9. doi: 10.1007/978-3-642-72624-8_90. Haematol Blood Transfus. 1987. PMID: 3481758
-
Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.Proc Natl Acad Sci U S A. 1989 Apr;86(7):2157-61. doi: 10.1073/pnas.86.7.2157. Proc Natl Acad Sci U S A. 1989. PMID: 2648391 Free PMC article.
-
Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.EMBO J. 1990 Apr;9(4):1157-64. doi: 10.1002/j.1460-2075.1990.tb08222.x. EMBO J. 1990. PMID: 2323336 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.J Virol. 1993 May;67(5):2853-61. doi: 10.1128/JVI.67.5.2853-2861.1993. J Virol. 1993. PMID: 8386279 Free PMC article.
Cited by
-
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.J Virol. 2013 Feb;87(4):2264-77. doi: 10.1128/JVI.01594-12. Epub 2012 Dec 12. J Virol. 2013. PMID: 23236059 Free PMC article.
-
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.J Virol. 2012 Sep;86(17):9055-69. doi: 10.1128/JVI.00793-12. Epub 2012 Jun 13. J Virol. 2012. PMID: 22696646 Free PMC article.
-
5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.Retrovirology. 2006 Oct 12;3:69. doi: 10.1186/1742-4690-3-69. Retrovirology. 2006. PMID: 17034647 Free PMC article.
-
Methylation: a regulator of HIV-1 replication?Retrovirology. 2007 Feb 2;4:9. doi: 10.1186/1742-4690-4-9. Retrovirology. 2007. PMID: 17274823 Free PMC article.
-
Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.J Virol. 2003 Apr;77(7):4025-32. doi: 10.1128/jvi.77.7.4025-4032.2003. J Virol. 2003. PMID: 12634362 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous